Buy Now Survata Beractant 25mg/ml Injection online from GlobMedIndia – The Trusted Medicine Exporter for Specialty Healthcare Medicines South Africa - Botswana, Lesotho, Mozambique, Namibia, Swaziland, Zimbabwe, Johannesburg, Cape Town, Pretoria, Polokwane, Germiston, Nelspruit .

Survata Beractant 25mg/ml Injection 

Survata Beractant 25mg/ml Injection is a pulmonary surfactant medicine containing Beractant, used primarily for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants. Beractant reduces surface tension within the lungs and helps premature babies breathe more effectively by improving lung expansion and oxygen exchange.

This medicine is administered in Neonatal Intensive Care Units (NICU) under the supervision of qualified pediatricians and neonatology specialists for infants with underdeveloped lungs and respiratory complications.

Contact Details for Orders

• 💬 WhatsApp: +91 9730316395
• 📞 Phone: +91 9730316395
• 📧 Email: info@globmedindia.com
• 🌐 Website: globmedsindia.com

Composition and Content

• Brand Name: Survata Beractant 25mg/ml Injection
• Generic Name: Beractant
• Strength: 25 mg/ml
• Dosage Form: Injection / Intratracheal Suspension
• Drug Category: Pulmonary Surfactant Therapy
• Administration Route: Intratracheal Administration

Uses and Treatments

Survata Beractant 25mg/ml Injection is used for:

• Respiratory Distress Syndrome (RDS) in premature infants
• Neonatal respiratory complications
• Lung immaturity in preterm babies
• Prevention of respiratory failure in neonates
• NICU respiratory support treatment

Beractant supports healthy lung function and helps premature infants breathe more efficiently.

How to Use

• Administered only by trained healthcare professionals in NICU settings.
• Given directly into the infant’s lungs through an endotracheal tube.
• Dosage is determined according to infant body weight and clinical condition.
• Continuous monitoring of breathing and oxygen levels is required after administration.

Do not administer outside specialized medical supervision.

Dosage Information

Dosage depends on:

• Infant body weight
• Severity of Respiratory Distress Syndrome
• Clinical condition of the newborn
• Response to therapy

Typical dosage:

• Administered according to neonatology treatment protocols prescribed by pediatric specialists.

Repeat dosing may be necessary depending on respiratory condition and oxygen support requirements.

Advantages of Survata Beractant 25mg/ml Injection

• Helps premature infants breathe effectively
• Reduces complications of Respiratory Distress Syndrome
• Supports proper lung expansion
• Widely used in neonatal intensive care
• Improves oxygen exchange in newborns
• Essential medicine for NICU respiratory management

Possible Side Effects

Common side effects may include:

• Temporary breathing difficulty
• Low oxygen levels
• Airway blockage
• Heart rate changes
• Blood pressure fluctuations

Continuous monitoring by healthcare professionals is essential during treatment.

Storage Conditions

• Store refrigerated between 2°C to 8°C.
• Do not freeze.
• Protect from direct sunlight.
• Store in original packaging.
• Keep out of reach of children.

Alternative Indian Brands for Beractant Injection

Alternative surfactant therapy brands may include:

• Survanta
• Curosurf
• Neosurf
• Bovsurf

Availability may vary according to hospital procurement policies and prescription regulations.

Why Choose GlobMedIndia?

• Trusted exporter of specialty medicines
• Genuine pharmaceutical products
• Secure packaging and global delivery
• Affordable international pricing
• Professional export support
• Reliable healthcare product supplier

Visit: GlobMedIndia Official Website

Buy Now Survata Beractant 25mg/ml Injection online from GlobMedIndia – The Trusted Medicine Exporter for Specialty Healthcare Medicines.